• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 1 型糖尿病成人患者中,使用餐时推注挑战来评估 Omnipod 个性化模型预测控制算法的性能。

Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.

机构信息

1 Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University , Stanford, California.

2 Diablo Clinical Research , Walnut Creek, California.

出版信息

Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.

DOI:10.1089/dia.2018.0138
PMID:30070928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6114075/
Abstract

BACKGROUND

This study assessed the safety and performance of the Omnipod personalized model predictive control (MPC) algorithm using an investigational device in adults with type 1 diabetes in response to overestimated and missed meal boluses and extended boluses for high-fat meals.

MATERIALS AND METHODS

A supervised 54-h hybrid closed-loop (HCL) study was conducted in a hotel setting after a 7-day outpatient open-loop run-in phase. Adults aged 18-65 years with type 1 diabetes and HbA1c 6.0%-10.0% were eligible. Primary endpoints were percentage time in hypoglycemia <70 mg/dL and hyperglycemia ≥250 mg/dL. Glycemic responses for 4 h to a 130% overestimated bolus and a missed meal bolus were compared with a 100% bolus for identical meals, respectively. The 12-h postprandial responses to a high-fat meal were compared using either a standard or extended bolus.

RESULTS

Twelve subjects participated in the study, with (mean ± standard deviation): age 35.4 ± 14.1 years, diabetes duration 16.5 ± 9.3 years, HbA1c 7.7 ± 0.9%, and total daily dose 0.58 ± 0.19 U/kg. Outcomes for the 54-h HCL period were mean glucose 153 ± 15 mg/dL, percentage time <70 mg/dL [median (interquartile range)]: 0.0% (0.0-1.2%), 70-180 mg/dL: 76.1% ± 8.0%, and ≥250 mg/dL: 4.5% ± 3.6%. After both the 100% and 130% boluses, postprandial percentage time <70 mg/dL was 0.0% (0.0-0.0%) (P = 0.50). After the 100% and missed boluses, postprandial percentage time ≥250 mg/dL was 0.2% ± 0.6% and 10.3% ± 16.5%, respectively (P = 0.06). Postprandial percentages time ≥250 mg/dL and <70 mg/dL were similar with standard or extended boluses for a high-fat meal.

CONCLUSIONS

The Omnipod personalized MPC algorithm performed well and was safe during day and night use in response to overestimated, missed, and extended meal boluses in adults with type 1 diabetes.

摘要

背景

本研究旨在评估 Omnipod 个体化模型预测控制(MPC)算法在接受过估算和错过餐时推注以及高脂肪餐时延长推注的 1 型糖尿病成人中的安全性和性能。

材料和方法

在门诊开环运行 7 天后,在酒店环境中进行了一项为期 54 小时的有监督混合闭环(HCL)研究。年龄在 18-65 岁之间、1 型糖尿病且糖化血红蛋白(HbA1c)为 6.0%-10.0%的成人符合条件。主要终点是血糖<70mg/dL 的时间百分比和血糖≥250mg/dL 的时间百分比。分别比较了 130%估算过量的推注和错过的餐时推注与相同餐食的 100%推注的 4 小时血糖反应。使用标准或延长推注比较高脂肪餐后 12 小时的餐后反应。

结果

12 名受试者参加了这项研究,(平均值±标准差):年龄 35.4±14.1 岁,糖尿病病程 16.5±9.3 年,HbA1c 7.7±0.9%,总日剂量 0.58±0.19U/kg。54 小时 HCL 期间的结果为平均血糖 153±15mg/dL,血糖<70mg/dL 的时间百分比[中位数(四分位距)]:0.0%(0.0-1.2%),70-180mg/dL:76.1%±8.0%,血糖≥250mg/dL:4.5%±3.6%。在 100%和 130%推注后,餐后血糖<70mg/dL 的时间百分比均为 0.0%(0.0-0.0%)(P=0.50)。在 100%和错过的推注后,餐后血糖≥250mg/dL 的时间百分比分别为 0.2%±0.6%和 10.3%±16.5%(P=0.06)。使用标准或延长推注时,高脂肪餐后血糖≥250mg/dL 和<70mg/dL 的百分比相似。

结论

在 1 型糖尿病成人中,Omnipod 个体化 MPC 算法在白天和夜间使用时表现良好且安全,可响应高估、错过和延长的餐时推注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/4a566aa0b94e/fig-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/fcea98465ea9/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/4ae2d123d4a8/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/0614d711138a/fig-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/4a566aa0b94e/fig-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/fcea98465ea9/fig-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/4ae2d123d4a8/fig-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/0614d711138a/fig-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2394/6114075/4a566aa0b94e/fig-4.jpg

相似文献

1
Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.在 1 型糖尿病成人患者中,使用餐时推注挑战来评估 Omnipod 个性化模型预测控制算法的性能。
Diabetes Technol Ther. 2018 Sep;20(9):585-595. doi: 10.1089/dia.2018.0138. Epub 2018 Aug 2.
2
Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.使用个性化模型预测控制算法的 1 型糖尿病成人、青少年和儿科患者中 OmniPod 混合闭环系统的安全性和可行性。
Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.
3
Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.1 型糖尿病成人中度强度运动条件下 Omnipod 个性化模型预测控制算法的性能。
Diabetes Technol Ther. 2019 May;21(5):265-272. doi: 10.1089/dia.2019.0017. Epub 2019 Mar 29.
4
Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.在自由生活条件下,5 天内,1 型糖尿病成人、青少年和儿童使用 Omnipod 混合闭环系统的安全性和性能。
Diabetes Technol Ther. 2020 Mar;22(3):174-184. doi: 10.1089/dia.2019.0286. Epub 2019 Oct 29.
5
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.闭环多模型概率预测控制器人工胰腺在监督下的宾馆环境中对青少年和成年人的性能。
Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.
6
Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.1型糖尿病青少年闭环治疗期间减少餐时大剂量胰岛素注射的安全性、有效性及葡萄糖代谢:一项随机临床试验
Diabetes Obes Metab. 2015 Dec;17(12):1173-9. doi: 10.1111/dom.12549. Epub 2015 Oct 9.
7
Hybrid Closed-Loop Insulin Delivery in Type 1 Diabetes During Supervised Outpatient Conditions.1型糖尿病患者在门诊监督条件下的混合闭环胰岛素输注
J Diabetes Sci Technol. 2016 May 3;10(3):708-13. doi: 10.1177/1932296816631568. Print 2016 May.
8
Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.采用皮下葡萄糖传感与胰岛素输注以及模型预测控制算法的闭环人工胰腺:弗吉尼亚州的经验。
J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8. doi: 10.1177/193229680900300506.
9
Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes.1型糖尿病的多中心闭环/混合餐时大剂量胰岛素输注
Diabetes Technol Ther. 2014 Oct;16(10):623-32. doi: 10.1089/dia.2014.0050. Epub 2014 Sep 4.
10
Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.使用吸入式技术球胰岛素模拟第一阶段胰岛素分泌的自动化人工胰腺的临床结果。
J Diabetes Sci Technol. 2015 May;9(3):564-72. doi: 10.1177/1932296815582061. Epub 2015 Apr 21.

引用本文的文献

1
Safety, efficacy and psychological impact of Omnipod hybrid closed loop system in children, adolescents, and adults in 24 h and nighttime: Systematic review with additional meta-analysis.Omnipod混合闭环系统在儿童、青少年和成人24小时及夜间的安全性、有效性和心理影响:系统评价及附加荟萃分析
J Diabetes Metab Disord. 2025 May 30;24(1):134. doi: 10.1007/s40200-025-01639-z. eCollection 2025 Jun.
2
7. Diabetes Technology: Standards of Care in Diabetes-2025.7. 糖尿病技术:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S146-S166. doi: 10.2337/dc25-S007.
3
Blood Glucose Prediction from Nutrition Analytics in Type 1 Diabetes: A Review.

本文引用的文献

1
Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.闭环多模型概率预测控制器人工胰腺在监督下的宾馆环境中对青少年和成年人的性能。
Diabetes Technol Ther. 2018 May;20(5):335-343. doi: 10.1089/dia.2017.0424. Epub 2018 Apr 16.
2
Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.使用个性化模型预测控制算法的 1 型糖尿病成人、青少年和儿科患者中 OmniPod 混合闭环系统的安全性和可行性。
Diabetes Technol Ther. 2018 Apr;20(4):257-262. doi: 10.1089/dia.2017.0346. Epub 2018 Feb 12.
3
1 型糖尿病营养分析的血糖预测:综述。
Nutrients. 2024 Jul 10;16(14):2214. doi: 10.3390/nu16142214.
4
7. Diabetes Technology: Standards of Care in Diabetes-2024.7. 糖尿病技术:2024年糖尿病护理标准
Diabetes Care. 2024 Jan 1;47(Suppl 1):S126-S144. doi: 10.2337/dc24-S007.
5
Real-World User and Clinician Perspective and Experience with MiniMed™ 780G Advanced Hybrid Closed Loop System.现实世界中用户和临床医生对美敦力780G高级混合闭环系统的看法与体验。
Diabetes Ther. 2023 Aug;14(8):1319-1330. doi: 10.1007/s13300-023-01427-z. Epub 2023 Jun 6.
6
7. Diabetes Technology: Standards of Care in Diabetes-2023.7. 糖尿病技术:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337/dc23-S007.
7
Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes.Omnipod 5自动胰岛素输送系统的临床应用:糖尿病患者培训与入门的关键考量因素
Clin Diabetes. 2022 Spring;40(2):168-184. doi: 10.2337/cd21-0083. Epub 2022 Apr 15.
8
A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670G.美敦力先进混合闭环系统与 670G 的餐后血糖控制比较。
Diabetes Technol Ther. 2022 Aug;24(8):573-582. doi: 10.1089/dia.2021.0568. Epub 2022 Apr 28.
9
Current Advances of Artificial Pancreas Systems: A Comprehensive Review of the Clinical Evidence.人工胰腺系统的最新进展:临床证据的综合评价。
Diabetes Metab J. 2021 Nov;45(6):813-839. doi: 10.4093/dmj.2021.0177. Epub 2021 Nov 22.
10
Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes.多中心试验:一种无管、体上自动化胰岛素输送系统,具有可定制的血糖目标,用于儿科和成年 1 型糖尿病患者。
Diabetes Care. 2021 Jul;44(7):1630-1640. doi: 10.2337/dc21-0172. Epub 2021 Jun 7.
Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial.
使用简化的推注策略的双激素人工胰腺错误餐时胰岛素推注的影响 - 一项随机对照试验。
Sci Rep. 2018 Feb 8;8(1):2621. doi: 10.1038/s41598-018-20785-4.
4
Standardizing Clinically Meaningful Outcome Measures Beyond HbA for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange.1型糖尿病HbA之外临床有意义结局指标的标准化:美国临床内分泌医师协会、美国糖尿病教育者协会、美国糖尿病协会、内分泌学会、国际青少年糖尿病研究基金会、利昂娜·M.和哈里·B.赫尔姆斯利慈善信托基金、儿科内分泌学会以及T1D交流组织的共识报告
Diabetes Care. 2017 Dec;40(12):1622-1630. doi: 10.2337/dc17-1624.
5
What End Users and Stakeholders Want From Automated Insulin Delivery Systems.终端用户和利益相关者对自动胰岛素输送系统的期望。
Diabetes Care. 2017 Nov;40(11):1453-1461. doi: 10.2337/dc17-0400. Epub 2017 Aug 25.
6
The Fallacy of Average: How Using HbA Alone to Assess Glycemic Control Can Be Misleading.平均的谬误:仅使用糖化血红蛋白(HbA)来评估血糖控制如何会产生误导。
Diabetes Care. 2017 Aug;40(8):994-999. doi: 10.2337/dc17-0636.
7
The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration.自动胰岛素给药的曙光:一个用于概念化胰岛素给药的新临床框架。
Pediatr Diabetes. 2018 Feb;19(1):14-17. doi: 10.1111/pedi.12535. Epub 2017 Jun 27.
8
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.人工胰腺系统对 1 型糖尿病患者血糖控制的影响:一项门诊随机对照试验的系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512. doi: 10.1016/S2213-8587(17)30167-5. Epub 2017 May 19.
9
Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System.1型糖尿病患者使用混合闭环系统后的期望和态度
Diabetes Educ. 2017 Apr;43(2):223-232. doi: 10.1177/0145721717697244.
10
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.1型糖尿病青少年和成人在家使用混合闭环胰岛素输送系统的血糖结果
Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089/dia.2016.0421. Epub 2017 Jan 30.